SELLAS Life Sciences Group, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
SELLAS Life Sciences Group, Inc. (SLS) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $526.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-19
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $368.00K.
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $0.00.
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-06-30 was $0.00.
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $526.00K, a 0.00% change from fiscal 2024.
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $526.00K, a 42.93% increase from fiscal 2023.
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $368.00K, a 18.04% decline from fiscal 2022.
- SELLAS Life Sciences Group, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $449.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $526.00K 10-K · filed 2026-03-19 | |||
| 2024-12-31 | $526.00K 10-K · filed 2026-03-19 | |||
| 2023-12-31 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $368.00K derived: sum of 2 quarters · filed 2025-03-20 | $368.00K derived: sum of 3 quarters · filed 2025-03-20 | $368.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $449.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $449.00K 10-Q · filed 2023-11-09 | $449.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $449.00K 10-Q · filed 2023-08-10 | $449.00K derived: sum of 3 quarters · filed 2023-08-10 | $449.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $449.00K 10-Q · filed 2023-05-11 | $449.00K derived: sum of 2 quarters · filed 2023-05-11 | $449.00K derived: sum of 3 quarters · filed 2023-05-11 | $449.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | $0.00 derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-05-12 | $853.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $853.00K derived: sum of 3 quarters · filed 2022-03-31 | $976.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $853.00K derived: sum of 2 quarters · filed 2021-11-12 | $976.00K 10-Q · filed 2021-11-12 | $975.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $853.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $976.00K 10-Q · filed 2021-08-12 | $975.00K derived: sum of 3 quarters · filed 2021-08-12 | $975.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $123.00K 10-Q · filed 2020-05-14 | $122.00K derived: sum of 2 quarters · filed 2021-03-23 | $122.00K derived: sum of 3 quarters · filed 2021-03-23 | $672.00K derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$1.00K derived: sum of 2 quarters · filed 2021-03-23 | $549.00K derived: sum of 3 quarters · filed 2021-03-23 | $549.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $550.00K derived: sum of 2 quarters · filed 2020-11-13 | $550.00K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $550.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $550.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |